Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747773 · ClinicalTrials.gov registry record · Phase 4
Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung
A Phase 4 study, sponsored by CSA Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT00747773 is a Phase 4 study that has completed, run by CSA Medical. The registered enrollment target is 21 participants.
The verdict
NCT00747773, a Phase 4 study, has completed, sponsored by CSA Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility and general safety in the human airway as well as assess the safety and depth and area of treatment using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB) using surgical resection specimens from patients undergoing lobectomy.
Interventions
- DEVICE CryoSpray Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00747773
The ClinicalTrials.gov registry entry for NCT00747773 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CSA Medical, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CryoSpray Ablation System is the first listed.
NCT00747773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00747773 about?
NCT00747773 is a clinical study titled "Cryospray Ablation of Surgical Resection Specimens To Determine Safety And Histological Effect In The Lung". The purpose of this study is to evaluate the feasibility and general safety in the human airway as well as assess the safety and depth and area of treatment using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB) using surgical resection specimens from patients u...
What is the current status of trial NCT00747773?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2007-11. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00747773?
The interventions under investigation include: CryoSpray Ablation System (DEVICE).
Who is sponsoring clinical trial NCT00747773?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.